• Search
  • Login
  • Register
Menu
  • Last issue
  • Home
  • News
  • CongressUpdate
  • Guidelines
  • Specials
  • Links
  • Reimbursement News
All
  • All
  • BJH articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here
News > Pharma News

Category

All
  • General
  • Healthy Living
  • Pharma News
  • Health of Tomorrow
  • Viewpoints
  • Art Corner
  • Fundraising
  • Prevention
  • Science
  • Clinical trials
  • Clinical practice
  • Corona
  • Medical Research
  • Health Innovation
  • Art on View
  • Podcasts
  • Therapy
  • Editor's pick
  • Covid-19
  • Society Announcement
  • Reimbursement News
  • Congress News

Specialty

All
  • Alle
  • YESCARTA
  • BEKEMV
  • NPLATE

Pharma News

Autologous cell therapy shows clinical benefits for multiple myeloma patients

Read more
subscribe Latest issue All issues Newsletters
Index latest issue
  • INTRODUCTION
  • Advancements in thrombophilia testing: The role of multi-gene panels in venous thromboembolism
  • The role of UBTF-TD mutations in paediatric acute myeloid leukaemia and myelodysplastic syndrome
  • Desensitisation as treatment option in patients with drug hypersensitivity
  • HMB-001: Novel treatment for Glanzmann thrombasthenia
  • Anti-IL6 receptor antibody for the treatment of immune checkpoint-related hemophagocytic lymphohistiocytosis
  • Highlights from EBMT 2025
  • Journal scan
  • New haematology reimbursements in Belgium
Pharma News

Fitusiran reduces bleeding events in patients with severe haemophilia

Read more
Pharma News

Fast track designation to Prothera’s mocravimod for AML patients receiving HSCT

Read more
Pharma News

FDA breakthrough designation to efanesoctocog alfa for haemophilia A

Read more
Pharma News

FDA approves the frontline use of ivosidenib in AML patients with IDH1 mutation

Read more
Pharma News

RMAT designation to obecabatagene autoleucel by FDA for patients with acute lymphoblastic leuk...

Read more
Pharma News

Axicabtagene ciloleucel shows promise as frontline therapy for high-risk large B-cell lymphoma

Read more
Pharma News

FDA approval for ciltacabtagene autoleucel for Relapsed/Refractory Multiple Myeloma

Read more
Pharma News

FDA: major safety concerns with Ukoniq, PI3K inhibitor drug for treatment of lymphoma

Read more
Previous 1 2 3 4 5 6 Next
Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJH
  • Advertisements & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJH is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJH 2025